- $511.56m
- $1.38bn
- $1.83bn
- 60
- 79
- 75
- 82
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,956 | 1,655 | 2,025 | 1,948 | 1,833 |
Cost of Revenue | |||||
Gross Profit | 634 | 492 | 615 | 552 | 598 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,760 | 1,543 | 1,874 | 1,913 | 1,783 |
Operating Profit | 196 | 112 | 151 | 34.8 | 49.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 164 | 78.6 | 111 | 14.9 | -13.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 107 | 62 | 102 | -13.2 | -21.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 107 | 62 | 102 | -13.2 | -21.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 107 | 62 | 102 | -13.2 | -21.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.14 | 0.776 | 1.27 | 0.6 | 0.534 |
Dividends per Share |